COST-EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PORTUGAL

被引：0
|
作者：
Laires, P. [1 ]
Tun-Ying, H. [2 ]
Ambegaonkar, B. M. [3 ]
Davies, G. M. [4 ]
机构：
[1] Merck Sharp & Dohme Ltd, Oeiras, Portugal
[2] Merck Sharp & Dohme Ltd, Whitehouse Stn, NJ USA
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Upper Gwynedd, PA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.995
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A371 / A371
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal
    Laires, Pedro A.
    Ejzykowicz, Flavia
    Hsu, Tun-Ying
    Ambegaonkar, Baishali
    Davies, Glenn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (08) : 565 - 572
  • [2] Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
    Michele Kohli
    Cheryl Attard
    Annette Lam
    Daniel Huse
    John Cook
    Chantal Bourgault
    Evo Alemao
    Donald Yin
    Michael Marentette
    [J]. PharmacoEconomics, 2006, 24 : 815 - 830
  • [3] Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada
    Kohli, Michele
    Attard, Cheryl
    Lam, Annette
    Huse, Daniel
    Cook, John
    Bourgault, Chantal
    Alemao, Evo
    Yin, Donald
    Marentette, Michael
    [J]. PHARMACOECONOMICS, 2006, 24 (08) : 815 - 830
  • [4] COST EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PATIENTS NOT AT LDL CHOLESTEROL TREATMENT GOAL IN BRAZIL
    Araujo, G. T.
    Fonseca, M.
    Etto, H.
    Davies, G. M.
    Hsu, T. Y.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [5] Cost effectiveness of atorvastatin (Lipitor) as single therapy and dual therapy with ezetimibe (Zetia)
    Bui, T
    Harrison, DL
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 268 - 268
  • [6] Cost-effectiveness of statin monotherapy and combination therapy with ezetimibe.
    Coleman, CI
    Gillespie, EL
    Gryskiewicz, KA
    White, M
    [J]. PHARMACOTHERAPY, 2005, 25 (03): : 470 - 470
  • [7] Modeling the cost-effectiveness of doubling atorvastatin's dose versus adding niacin ER
    Olson, BM
    Malone, DC
    [J]. FORMULARY, 2001, 36 (10) : 730 - +
  • [8] GENERIC ATORVASTATIN, THE BELGIAN STATIN MARKET AND THE COST-EFFECTIVENESS OF STATIN THERAPY
    Simoens, S.
    Sinnaeve, P.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A381 - A381
  • [9] Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy
    Steven Simoens
    Peter R. Sinnaeve
    [J]. Cardiovascular Drugs and Therapy, 2013, 27 : 49 - 60
  • [10] Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy
    Simoens, Steven
    Sinnaeve, Peter R.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (01) : 49 - 60
12345